Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi Launches High Tech Vaccine Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sanofi Launches High Tech Vaccine Facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi Pasteur, the vaccines unit of Sanofi-Aventis, has established a new automated vaccine production facility in Val de Reuil, France to respond to increased vaccine demand worldwide. This new $156 million facility incorporates the latest technology and is part of the $935 million that the company has invested in France between 2005 and 2008.
   
“Sanofi Pasteur’s commitment to global health is exemplified by significant investments in vaccine production infrastructures. These efforts are aimed at meeting a world demand for vaccines expected to double by 2016,” said Wayne Pisano, president and chief executive officer of Sanofi Pasteur, who inaugurated the new production unit. “The new facility will provide high-end production work environment for dedicated people who produce vaccines for the world.”
   
The new facility can produce vaccines against 20 diseases and is designed to respond to pandemic flu, once the flu strain is identified by the World Health Organization. Construction of the 7,800-square-meter building began in 2006 and is projected to be operational by the end of this year. The facility is scaled to fill 200 million syringes and vials per year, twice the current capacity at this site.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics